Homeopathy
DOI: 10.1055/s-0044-1790513
Clinical Case Report

Homeopathic Management of Bulky Uterus with Uterine Fibroid in a 40-year-old Patient: An Evidence-Based Case Report

1   Department of Clinical Research, Central Council for Research in Homoeopathy, New Delhi, India
,
Shweta Singh Kureel
1   Department of Clinical Research, Central Council for Research in Homoeopathy, New Delhi, India
› Author Affiliations
Funding None.

Abstract

Background Uterine fibroids are benign gynecological tumours that arise in the uterine smooth muscle tissue and are characterized by the production of excessive quantities of extracellular matrix. Various therapeutic options, from medical management to surgical intervention, exist for uterine fibroids, for which homeopathy has emerged as a promising therapeutic option in patient-centered care.

Case History A 40-year-old woman presented with complaints of heavy menstrual bleeding, with pain in the pelvic region and back. She was diagnosed as a case of bulky uterus with uterine fibroid. The patient opted for homeopathic management and was prescribed Thuja occidentalis based on individualization, miasmatic analysis and repertorial totality.

Results After treatment, there was regression in size of the fibroid within 5 months, with complete resolution and restoration of the uterus to normal size within 9 months. Changes were validated through ultrasonography, which added objective evidence to the positive outcome. The Modified Naranjo Criteria for Homeopathy (MONARCH) inventory total score was +9, which indicated causal attribution of clinical outcome to the homeopathic intervention.

Conclusion This case study has illustrated the clinical benefits of homeopathy in the management of a patient with uterine fibroids, reaffirming the need for further research to explore its value as a therapeutic option for individuals seeking alternative or complementary approaches for appropriate medical conditions.

Authors' Contribution

B.W. treated the case. B.W. and S.S.K. drafted then edited and prepared the final manuscript for submission.


Supplementary Material



Publication History

Received: 20 June 2024

Accepted: 12 August 2024

Article published online:
30 December 2024

© 2024. Faculty of Homeopathy. This article is published by Thieme.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

 
  • References

  • 1 Bulun SE. Uterine fibroids. N Engl J Med 2013; 369: 1344-1355
  • 2 Davis BJ, Risinger JI, Chandramouli GV, Bushel PR, Baird DD, Peddada SD. Gene expression in uterine leiomyoma from tumors likely to be growing (from black women over 35) and tumors likely to be non-growing (from white women over 35). PLoS One 2013; 8: e63909
  • 3 Stewart EA, Laughlin-Tommaso SK, Catherino WH, Lalitkumar S, Gupta D, Vollenhoven B. Uterine fibroids. Nat Rev Dis Primers 2016; 2: 16043
  • 4 Li Z, Maeda D, Kudo-Asabe Y. et al. MED12 is frequently mutated in ovarian and other adnexal leiomyomas. Hum Pathol 2018; 81: 89-95
  • 5 Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 2003; 188: 100-107
  • 6 Stewart EA, Cookson CL, Gandolfo RA, Schulze-Rath R. Epidemiology of uterine fibroids: a systematic review. BJOG 2017; 124: 1501-1512
  • 7 Swain D, Yadav C, Kumari J, Rani M, Rongmei PD, Khurana SK. Predictors and symptomatic burden of uterine fibroids among women in South-Eastern India: a cross-sectional survey analysis. Int J Reprod Contracept Obstet Gynecol 2019; 8: 524-530
  • 8 Medikare V, Kandukuri LR, Ananthapur V, Deenadayal M, Nallari P. The genetic bases of uterine fibroids; a review. J Reprod Infertil 2011; 12: 181-191
  • 9 Moore SD, Herrick SR, Ince TA. et al. Uterine leiomyomata with t(10;17) disrupt the histone acetyltransferase MORF. Cancer Res 2004; 64: 5570-5577
  • 10 Flake GP, Andersen J, Dixon D. Etiology and pathogenesis of uterine leiomyomas: a review. Environ Health Perspect 2003; 111: 1037-1054
  • 11 Shen Y, Xu Q, Xu J, Ren ML, Cai YL. Environmental exposure and risk of uterine leiomyoma: an epidemiologic survey. Eur Rev Med Pharmacol Sci 2013; 17: 3249-3256
  • 12 Al-Hendy A, Myers ER, Stewart E. Uterine fibroids: burden and unmet medical need. Semin Reprod Med 2017; 35: 473-480
  • 13 Luthra J, Chattopadhyay A, Nayak C. et al. Aurum muriaticum natronatum in treatment of uterine fibroids: a randomized trial. J Appl Sci Clin Pract 2023; 4: 31
  • 14 Oberai P, Indira B, Varanasi R. et al. A multicentric randomized clinical trial of homoeopathic medicines in fifty millesimal potencies vis-à-vis centesimal potencies on symptomatic uterine fibroids. Indian J Res Homoeopathy 2016; 10: 24-35
  • 15 Quadri IJ, Ali MS, Vatsalya B, Ponnam HB, Parveen NS. Role of homoeopathic medicines in treating uterine fibroid: a prospective observational study. Ind J Res Homoeopathy 2012; 6: 8-14
  • 16 Maiti BP, Khadim AI, Jamatia S. Management of uterine fibroid with homoeopathy: a case report. J Intgr Stand Homoeopathy 2023; 6: 137-143
  • 17 Shinde V. Polycystic ovarian syndrome with endometrial hyperplasia and uterine fibroids treated with homoeopathy: a case report. Indian J Res Homoeopathy 2022; 16: 231-238
  • 18 Quadri Iqbal J, Ali MS, Parveen NS, Vatsalya B. A case of uterine fibroid. Indian J Res Homoeopathy 2008; 2: 50-55
  • 19 Roberts HA. The Principles and Art of Cure by Homeopathy. Third Edition. New Delhi, India: B Jain Publishers; 2002
  • 20 van Haselen RA. Homeopathic clinical case reports: Development of a supplement (HOM-CASE) to the CARE clinical case reporting guideline. Complement Ther Med 2016; 25: 78-85
  • 21 Lamba CD, Gupta VK, van Haselen R. et al. Evaluation of the Modified Naranjo Criteria for assessing causal attribution of clinical outcome to homeopathic intervention as presented in case reports. Homeopathy 2020; 109: 191-197
  • 22 Clarke JH. Dictionary of Practical Materia Medica. Reprint ed. New Delhi: B. Jain Publishers (Pvt.) Ltd.,; 1999. , III.
  • 23 Burnett JC. Vaccinosis and its Cure by Thuja: With Remarks on Homeoprophylaxis. Fifth Edition. New Delhi, India: B Jain; 2021
  • 24 Pizzorno JE, Murray MT, Joiner H. The Clinician's Handbook of Natural Medicine. Third Edition. London, United Kingdom: Churchill Livingstone(P); 2016. pages 936-944
  • 25 Caruntu S, Ciceu A, Olah NK, Don I, Hermenean A, Cotoraci C. Thuja occidentalis L. (Cupressaceae): ethnobotany, phytochemistry and biological activity. Molecules 2020; 25: 5416
  • 26 Akkol EK, İlhan M, Demirel MA, Keleş H, Tümen I, Süntar İ.. Thuja occidentalis L. and its active compound, α-thujone: Promising effects in the treatment of polycystic ovary syndrome without inducing osteoporosis. J Ethnopharmacol 2015; 168: 25-30
  • 27 Ghosh S, Naftalin J, Imrie R, Hoo WL. Natural history of uterine fibroids: a radiological perspective. Curr Obstet Gynecol Rep 2018; 7: 117-121